Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.

Citation: Bey E, Marchais-Oberwinkler S, Kruchten P, Frotscher M, Werth R, Oster A, Algül O, Neugebauer A, Hartmann RW.: Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases. Bioorg Med Chem, Volume 16 (12), 2008
Authors: Algül O, Bey E, Frotscher M, Hartmann RW., Kruchten P, Marchais-Oberwinkler S, Neugebauer A, Oster A, Werth R
Journal: Bioorg Med Chem
Year: 2008
DOI: 10.1016/j.bmc.2008.04.073
PubMed: 18514529
Machine-readable: REST API RDF

Publication